This Guideline addresses a number of medical issues which neurologists and other medical doctors who are involved in the medical management of patients with dementia are confronted with on a regular basis.
Search results for
"paper"
-
-
Breaking newsEAN NewsCOVID-19Research
COVID-19 and decompressive hemicraniectomy for acute ischemic stroke
July 27, 2020In this paper, the authors retrospectively reviewed all COVID-19–positive patients admitted to the neuroscience intensive care unit for monitoring of malignant cerebral oedema -
Breaking newsEAN NewsCOVID-19Research
Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID‐19
July 27, 2020In this paper recently published in Acta Neuropathologica, the authors report neuropathology of two COVID-19 patients. -
Breaking newsEAN NewsCOVID-19Research
Characteristics and outcomes in patients with COVID-19 and acute ischaemic stroke. The global COVID-19 stroke registry
July 27, 2020In this paper, the authors pooled all consecutive patients hospitalised with laboratory-confirmed COVID-19 and acute ischaemic stroke across 28 sites from 16 countries. -
Breaking newsEAN NewsCOVID-19Research
Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection
July 27, 2020In this paper, the authors report a case of a previously healthy 58-year-old man who acutely developed hyposmia, generalised myoclonus, fluctuating and transient changes in level of consciousness, opsoclonus and an asymmetric hypokinetic-rigid syndrome with ocular abnormalities following severe SARS-CoV-2 infection. -
Breaking newsEAN NewsCOVID-19Research
Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 Coronavirus
July 27, 2020In this paper recently published in the official journal of the Hungarian Society of Neurologists, the authors discuss neurological signs and symptoms in COVID-19 patients; the effects of COVID-19 on services for other acute diseases; and changes in the care for patients with chronic neurological disorders. -
Submission of papers is open for the David Marsden Award 2021.
-
Clinical Fellowship Reports 2019
-
Research HighlightsEAN NewsCOVID-19ResearchTop Articles
Neurology Update: COVID-19 & Neuroscience/ Translational neurology
July 7, 2020COVID Breaking news: CNS injury biomarkers elevated in COVID patients -
In order to fill educational gap, CoCoCare developed a state-of-the-art educational program for residents across Europe
-
Breaking newsEAN NewsCOVID-19Research
Breaking News: Neuropathological features of Covid-19
June 23, 2020In this paper, just published in the New England Journal of Medicine, the authors report neuropathological findings from autopsies of 18 consecutive patients with SARS-CoV-2 infection who died in a single teaching hospital between April 14 and April 29, 2020. -
Breaking newsEAN NewsCOVID-19Research
Breaking News: Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry
June 23, 2020In this paper recently published in Neurology, the authors aimed to determine whether neurological manifestations are common in hospitalised COVID-19 patients and to describe their main characteristics. -
Breaking newsEAN NewsCOVID-19Research
Breaking News: Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2
June 23, 2020In this paper, the authors report a case of Guillain-Barré syndrome (GBS) with onset 2 weeks after SARS-CoV-2 infection and highly elevated serum antibodies against SARS-CoV-2, supporting an association between SARS-CoV-2 disease and GBS. -
Breaking newsEAN NewsCOVID-19Research
Breaking News: Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
June 23, 2020In this paper, the authors systematically analysed lung tissue samples from 38 patients who died from COVID-19 in two hospitals in northern Italy between Feb 29 and March 24 2020. -
Breaking newsEAN NewsCOVID-19ResearchTop Articles
Breaking News: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
June 23, 2020In this paper, just published in Lancet, the authors performed a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine in Wuhan, China.